National Women Physicians Day

.video-table { margin: auto; } .row { display: flex; flex-direction: row; flex-wrap: wrap; width: 100%; } .column { display: flex; flex-direction: column; flex-basis: 100%; flex: 2; }

In honor of National Women Physicians day on February 3rd, Rutgers Cancer Institute conducted several interviews to highlight our own.

 

Validation of Novel Prognostic Index May Better Inform Burkitt Lymphoma Treatment

Physician Profile

James K. Aikins Jr., MD, FACOG, FACS

James K. Aikins Jr., MD, FACOG, FACS

    Jump to section:
    First Patient Recently Treated with New Non-Surgical Therapy for Urothelial Cancer at Rutgers Cancer Institute
    Faculty Named Emerging Scholar
    Identification of Tamoxifen Resistance Markers Can Play Role in Breast Cancer Treatment Planning

    CAR T-Cell Therapy Available at Rutgers Cancer Institute and Robert Wood Johnson University Hospital

    Between 60 to 70 percent of patients with aggressive non-Hodgkin lymphoma are cured with initial chemotherapy and a significant percentage of patients who relapse are cured with a stem cell transplant using the patient’s own cells. However, in patients whose disease becomes resistant to chemotherapy, the average survival is only six months. Until recently, those with B-cell lymphomas that did not respond to standard therapies had limited treatment options.

    Subscribe to